Correlation Between TTY Biopharm and Medigen Biotechnology

Can any of the company-specific risk be diversified away by investing in both TTY Biopharm and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TTY Biopharm and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TTY Biopharm Co and Medigen Biotechnology, you can compare the effects of market volatilities on TTY Biopharm and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TTY Biopharm with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of TTY Biopharm and Medigen Biotechnology.

Diversification Opportunities for TTY Biopharm and Medigen Biotechnology

0.71

Correlation Coefficient

TTY Biopharm  Medigen Biotechnology

Poor diversification

The 3 months correlation between TTY and Medigen is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding TTY Biopharm Co and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and TTY Biopharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TTY Biopharm Co are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of TTY Biopharm i.e., TTY Biopharm and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between TTY Biopharm and Medigen Biotechnology

Assuming the 90 days trading horizon TTY Biopharm is expected to generate 1.56 times less return on investment than Medigen Biotechnology. But when comparing it to its historical volatility, TTY Biopharm Co is 2.14 times less risky than Medigen Biotechnology. It trades about 0.05 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  3,240  in Medigen Biotechnology on December 30, 2024 and sell it today you would earn a total of  100.00  from holding Medigen Biotechnology or generate 3.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.25%
Values	Daily Returns

TTY Biopharm Co  vs.  Medigen Biotechnology

TTY Biopharm

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in TTY Biopharm Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, TTY Biopharm is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medigen Biotechnology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Medigen Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with TTY Biopharm and Medigen Biotechnology

The main advantage of trading using opposite TTY Biopharm and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TTY Biopharm position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.

The idea behind TTY Biopharm Co and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.